Rozelle Hegeman‐Dingle

ORCID: 0000-0003-3568-1566
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Musculoskeletal pain and rehabilitation
  • Atrial Fibrillation Management and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Pharmaceutical industry and healthcare
  • Pediatric Pain Management Techniques
  • Social Media in Health Education
  • Medication Adherence and Compliance
  • Pain Mechanisms and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Cardiovascular Health and Risk Factors
  • Liver Disease Diagnosis and Treatment
  • Clinical practice guidelines implementation
  • Cardiac Arrhythmias and Treatments
  • Liver Disease and Transplantation
  • Diabetes Management and Education
  • Liver Diseases and Immunity
  • Venous Thromboembolism Diagnosis and Management
  • Opioid Use Disorder Treatment
  • Telemedicine and Telehealth Implementation
  • Central Venous Catheters and Hemodialysis
  • Mobile Health and mHealth Applications
  • Lipoproteins and Cardiovascular Health
  • Pain Management and Opioid Use

Pfizer (United States)
2014-2023

To estimate all-cause healthcare resource utilization and costs among chronic pain patients within an integrated delivery system in the United States.Electronic medical records health claims data from Henry Ford Health System were used to determine for with 24 conditions. Patients identified by ≥ 2 ICD-9-CM codes 30 days apart January December, 2010; first ICD-9 code was index event. Continuous coverage 12 months pre- postindex required. All-cause direct determined billing data.A total of...

10.1111/papr.12357 article EN Pain Practice 2015-10-07

There is a paucity of published data on the prevalence chronic pain conditions within large, integrated healthcare organizations in U.S.A. Such are essential to inform development appropriate treatment programs.Twenty-five selected were used identify patients receiving care Henry Ford Health System (HFHS) who enrolled Alliance Plan (HAP), subsidiary HFHS. Patients aged ≥ 18 years, HAP 2010, and having 2 encounters, 30 days apart, with an ICD-9-CM diagnosis code for condition interest during...

10.1111/papr.12334 article EN Pain Practice 2015-07-30

Although the American Heart Association and other professional societies have recommended shared decision-making as a way for patients with atrial fibrillation (AF) or flutter to make informed decisions about using anticoagulation (AC), best method facilitating remains uncertain.The aim of this study is assess AFib 2gether mobile app usability, perceived usefulness, extent nature that occurred clinical encounters between AF their cardiology providers in which was used.We identified visiting...

10.2196/27016 article EN cc-by JMIR Cardio 2021-10-03

Background Despite guideline‐recommended use of oral anticoagulation (OAC) for stroke prevention in atrial fibrillation (AF), OAC medication adherence among patients with AF the United States ranges from 47% to 82%. To characterize potential causes nonadherence, we analyzed associations between community and individual social risk factors AF. Methods Results A retrospective cohort analysis was conducted using IQVIA PharMetrics Plus claims data January 2016 June 2020, 3‐digit ZIP code‐level...

10.1161/jaha.122.026745 article EN cc-by-nc-nd Journal of the American Heart Association 2023-04-07

The Centers for Disease Control and Prevention has estimated that atrial fibrillation (AF) affects between 2.7 million 6.1 people in the United States. Those who have AF tend to a much higher stroke risk than others. Although most individuals with benefit from anticoagulation (AC) therapy, significant majority are hesitant start it. To add, providers often struggle helping patients negotiate decision AC therapy. assist communication regarding preferences knowledge about different strategies...

10.2196/21986 article EN cc-by JMIR Research Protocols 2021-01-15

Objective: Collecting data that helps evaluate different types of pain may improve physicians' decision-making with regard to treatment selection and on-going monitoring patients. To date, no chronic assessments have been widely implemented in primary care. The aim this study was psychometrically validate the electronic Chronic Pain Questions (eCPQ) a care setting.Research design methods: All men women ≥18 years arriving at two similar clinics southeastern Michigan were invited participate....

10.1080/03007995.2016.1240666 article EN Current Medical Research and Opinion 2016-11-10

Objective: The Chronic Pain Questions (CPQ) were developed for clinical use with the aim of supporting primary care physicians in screening, assessment and monitoring patients chronic pain. purpose this study was to examine ability cpq CPQ discriminate between neuropathic pain (nep) versus those sensory hypersensitivity (sh).Methods: Adult men women a diagnosis NeP or SH condition recruited from 5 sites across United States. Participants completed series self-administered questionnaires,...

10.1080/00325481.2017.1267538 article EN Postgraduate Medicine 2016-11-30

<sec> <title>BACKGROUND</title> The Centers for Disease Control and Prevention has estimated that atrial fibrillation (AF) affects between 2.7 million 6.1 people in the United States. Those who have AF tend to a much higher stroke risk than others. Although most individuals with benefit from anticoagulation (AC) therapy, significant majority are hesitant start it. To add, providers often struggle helping patients negotiate decision AC therapy. assist communication regarding preferences...

10.2196/preprints.21986 preprint EN 2020-09-17

The Electronic Chronic Pain Questions (eCPQ) has been developed to help healthcare providers systematically capture chronic pain data. This study evaluated the impact of using eCPQ on patient-reported outcomes (PROs) and resource utilization (HCRU) in a primary care setting, patient physician perceptions regarding use of, satisfaction with, eCPQ.This was prospective pragmatic conducted at Internal Medicine clinic within Henry Ford Health (HFH) Detroit campus between June 2017 April 2020....

10.3389/fmed.2023.933975 article EN cc-by Frontiers in Medicine 2023-06-22

Introduction: Patients with ASCVD are at increased risk for CV events. The 2018 AHA/ACC lipid guidelines recommend treating these patients high intensity or maximally tolerated statin therapy. objective of this study was to describe lowering treatment (LLT) patterns and values across 7 regional health systems. Methods: We conducted a cross-sectional analysis electronic records transformed into the PCORnet common data model (CDM) from sites in PaTH Clinical Research Network. Adults were...

10.1161/circ.146.suppl_1.12482 article EN Circulation 2022-11-08

<sec> <title>BACKGROUND</title> Although the American Heart Association and other professional societies have recommended shared decision-making as a way for patients with atrial fibrillation (AF) or flutter to make informed decisions about using anticoagulation (AC), best method facilitating remains uncertain. </sec> <title>OBJECTIVE</title> The aim of this study is assess AFib 2gether mobile app usability, perceived usefulness, extent nature that occurred clinical encounters between AF...

10.2196/preprints.27016 preprint EN 2021-01-20
Coming Soon ...